Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat

Endocrinology

Volumn 137, Issue 2, 1996, Pages 455-463

  Turnbull, Andrew V ^a   Rivier, Catherine ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; IBUPROFEN; INTERLEUKIN 6; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; TURPENTINE; VASOPRESSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG POTENTIATION; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0030021451     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.2.8593789     Document Type: Article

References (67)

1. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
2. Turnbull AV, Rivier CL Regulation of the HPA axis by cytokines. Brain Behav Immun, in press
3. Navarra P, Tsagaiakis S, Faria M, Rees LH, Besser GM, Grossman AB 1991 Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128:37-44
4. Morimoto A, Murakami N, Nakamori T, Sakata Y, Watanabe T 1989 Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1. J Physiol 411:245-256
5. Rivier C, Vale W 1991 Stimulatory effect of interleukin-1 on ACTH secretion in the rat: is it modulated by prostaglandins? Endocrinology 129:384-388
6. Sharp BM, Matta SG 1993 Prostaglandins mediate the adrenocorticotropin response to tumor necrosis factor in rats. Endocrinology 132:269-274
7. Rivier C, Shen GH 1994 In the rat, endogenous nitric oxide modulates the response of the hypothalamo-pituitary-adrenal axis to interleukin-1β, vasopressin, and oxytocin. J Neurosci 14:1985-1993
8. 1-adrenergic receptors. Endocrinology 136:3597-3603
9. Tilders FJH, De Rijk RH, Van Dam A-M, Vincent VA, Schotanus K, Persoons JHA 1994 Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology 19:209-232
10. Givalois L, Dornand J, Mekaouche M, Solier MD, Bristow AF, Ixart G, Siaud I, Assenmacher I, Barbanel G 1994 Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am J Physiol 267:R164-R170
11. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Godman M 1994 Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24: 1167-1171
12. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM 1994 Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and non-septic origin. Crit Care Med 22:550-551
13. Van Zee K, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF 1992 Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vim. Proc Natl Acad Sci USA 89:4845-4949
14. Giri JG, Wells J, Dower SK, McCall CE, Guzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE, Alderson MR 1994 Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol 153: 5802-5809
15. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA 1991 Production of interleukin-1-receptor antaonist during experimental endotoxaemia. Lancet 338: 1423-1424
16. Cooper AL, Brouwer S, Turnbull AV, Luheshi GN, Hopkins SJ, Kunkel SL, Rothwell NJ 1994 Tumor necrosis factor-alpha and fever after peripheral inflammation in the rat. Am J Physiol 36: R1431-R1436
17. Dawson J, Rordorf-Adam C, Geiger T, Towbin H, Kunz S, Nguyen H, Zingel O, Chaplin D, Vosbeck K 1993 Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugs. Agents Actions 38:255-264
18. Ferrandiz ML, Foster SJ 1991 Tumor necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions 32:289-294
19. Turnbull AV, Dow RC, Hopkins SJ, White A, Fink G, Rothwell NJ 1994 Mechanism of the activation of the pituitary-adrenal axis by tissue injury in the rat. Psychoneuroendocrinology 19:165-178
20. Ford HR, Hoffman RA, Wing EJ, Magee DM, McIntyre L, Simmons RL 1989 Characterization of wound cytokines in the sponge matrix model. Arch Surg 124:1422-1428
21. Sekut L, Menius JA, Brackeen MF, Connolly KM 1994 Evaluation of the significance of elevated levels of sytemic and localized tumor necrosis factor in different animal models of inflammation. J Lab Clin Med 124:813-820
22. Hopkins SJ 1990 Cytokines and their significance in rheumatic disease In: Orme MCLE (ed) Anti-Rheumatic Drugs. Pergamon Press, New York, pp 49-118
23. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zingernagel R, Bluethmann H, Kohler G 1994 Impaired immune and acute-phase responses in interleukin-6 deficient mice. Nature 368:339-342
24. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP 1991 Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254:421-423
25. Patchev VK, Mastorakos GM, Brady LS, Redwine J, Wilder RL, Chrousos GP 1993 Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 58:106-110
26. Davies P, MacIntyre DE 1992 Prostaglandins and inflammation. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: Basic Principles and Clinical Correlates, ed 2. Raven Press, New York, pp 123-138
27. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH 1994 N-Monomethyl arginine, an inhibitor of nitric oxide synthase, supresses the development of adjuvant arthritis in rats. Arthritis Rheum 37:1062-1069
28. Rivier C 1994 Endogenous nitric oxide paricipates in the activation of the hypothalamic-pituitary-adrenal axis by noxious stimuli. Endoer J 2:367-373
29. MacLeod RM, Hughes FM, Gorospe WC, Spangelo BL 1993 Synthesis, release, and actions of interleukin 6 in neuroendocrine tissues: methods and overview. Methods Neurosci 17:3-15
30. Turnbull AV 1993 Mechanisms of the Febrile and Pituitary-Adrenal Responses to Tissue Injury in the Rat. PhD Thesis, Manchester University, Manchester
31. Pozzoli G, Costa A, Grimaldi M, Schettini G, Preziosi P, Grossman A, Navarra P 1994 Lipopolysaccharide modulation of eicosanoid and corticotropin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factor. J Endocrinol 140:103-109
32. Hagan P, Poole S, Bristow AF 1993 Endotoxin-stimulated production of rat hypothalamic interleukin-1β in vivo and in vitro, measured by specific immunoradiometric assay. J Mol Endocrinol 11:31-36
33. Svanes K 1971 Diphasic increase in vascular permeability in turpentine induced inflammation in skin and musculature of mice. Acta Pathol Microbiol Scand [A] 79:335-344
34. Ling CR, Foster MA 1982 Changes in NMR relaxation time associated with local inflammatory response. Phys Med Biol 27:853-859
35. Paajanen H, Grodd W, Revel D, Engelstad B, Brasch RC 1987 Gadolium-DTPA enhanced MR imaging of intramuscular abscesses. Magn Reson Imaging 5:109-115
36. Wusteman M, Wight DGD, Elia M 1990 Protein metabolism after injury with turpentine: a rat model for clinical trauma. Am J Physiol 259:E763-E769
37. Woloski BMRNJ, Jamieson JC 1987 Rat corticotropin, insulin and thyroid hormone levels during the acute phase response to inflammation. Comp Biochem Physiol 86:15-19
38. Savu L, Zouaghi H, Nunez EA 1985 Serum inflammatory responses of transcortin binding activities and of total and free corticosterone and progesterone levels in developing rats: a kinetic approach. Int J Tissue React 7:443-448
39. Ballmer PE, McNurlan MA, Southern BG, Grant I, Garlick PJ 1991 Effects of human interleukin-1 beta on protein synthesis in rat tissues compared with a classical acute-phase response reaction induced by turpentine. Biochem J 279:683-688
40. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL 1992 Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 130:1775-1779
41. Kaneko M, Kaneko K, Shinsako J, Dallman MF 1981 Adrenal sensitivity to adrenocorticotropin varies diurnally. Endocrinology 109:70-75
42. Cooper AL, Rothwell NJ 1991 Mechanisms of early and late hypermetabolism and fever following localized tissue injury in rats. Am J Physiol 261:E698-E708
43. Rivier C, Vale W 1983 Interaction of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on ACTH secretion in vivo. Endocrinology 113:939-942
44. Rivier C, Plotsky PM 1986 Mediation by corticotropin-releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 48:475-494
45. Suda T, Tozawa F, Ushiyama T, Sumitomo T, Yamada M, Demura H 1990 Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126:1223-1228
46. Lee S, Rivier C 1994 Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-1 systemically or into the brain ventricles. J Neuroendocrinol 6:217-224
47. Yasin SA, Costa A, Forsling ML, Grossman A 1994 Interleukin-1β and interleukin-6 stimulate neurohypophysial hormone release in vitro. J Neuroendocrinol 6:179-184
48. Spinedi E, Hadid R, Daneva T, Gaillard RC 1992 Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action. Neuroendocrinology 56:46-53
49. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W 1987 Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524
50. Berkenbosch F, Van Oers J, del Key A, Tilders F, Besedovsky H 1987 Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238:524-526
51. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H 1988 Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely moving rats. Biochem Biophys Res Commun 155:1459-1463
52. Bernardini R, Kamilaris TC, Calogero AE, Johnson EO, Gomez MT, Gold PW, Chrousos GP 1990 Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126:2876-2881
53. Sirko S, Bishai I, Coceani F 1989 Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens. Am J Physiol 263:R616-R624
54. Iadecola C, Xu X, Zhang F, Hu J, el-Fakahany EE 1994 Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 19:501-505
55. Buttery LDK, Evans TJ, Springall DR, Carpenter A, Cohen J, Polak JM 1994 Immunocytochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest 71:755-764
56. Kaur H, Halliwell B 1994 Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350:9-12
57. Ialenti A, Ianaro A, Moncada S, Di Rosa M 1992 Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211:177-182
58. Laskin JD, Heck DE, Laskin DL 1994 Multifunctional role of nitric oxide in inflammation. Trends Endocrinol Metab 5:377-382
59. Torres G, Lee S, Rivier C 1993 Ontogeny of the rat hypothalamic nitric oxide synthase and colocalization with neuropeptides. Mol Cell Neurosci 4:155-163
60. Bredt DS, Hwang PM, Snyder SH 1990 Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770
61. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfelt T 1993 Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 90:11292-11296
62. Brunetti L, Preziosi P, Ragazzoni E, Vacca M 1993 Involvement of nitric oxide in basal and interleukin-1 beta-induced CRF and ACTH release in vitro. Life Sci 53:219-222
63. Costa A, Trainer P, Besser M, Grossman A 1993 Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 605:187-192
64. Karanth S, Lyson K, McCann SM 1993 Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90:3383-3387
65. Raber J, Koob GF, Bloom FE 1995 Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 272:815-824
66. Sandi C, Guaza C 1995 Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur J Pharmacol 274:17-23
67. Yasin S, Costa A, Trainer P, Windle R, Forsling ML, Grossman A 1993 Nitric oxide modulates the release of vasopressin from rat hypothalamic explants. Endocrinology 133:1466-1469